Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Harry Janssen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Living Beings
Concepts & Ideas
Anatomy
Procedures
Sign-in to see full Profile
Network (preview)
48
Schalm, Solko
37
de Man, Robert
24
Hansen, Bettina
22
Niesters, Hubert
15
Sprengers, Dave
15
van der Molen, Renate
14
Kusters, Johannes
12
Kwekkeboom, Jaap
12
Murad, Sarwa Darwish
10
van Zonneveld, Monika
10
zondervan, pieter
9
Tang, Thjon
9
Flink, Hajo
9
Binda, Rekha
8
Leebeek, Frank
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Harry Janssen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Boonstra Andre; van der Laan Luc J W; Vanwolleghem Thomas; Janssen Harry L A
Experimental models for hepatitis C viral infection.
Hepatology (Baltimore, Md.) 2009;50(5):1646-55.
-
2009: Op den Brouw Marjoleine L; Binda Rekha S; Geijtenbeek Teunis B H; Janssen Harry L A; Woltman Andrea M
The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells.
Virology 2009;393(1):84-90.
-
2009: Hoekstra Jildou; Leebeek Frank W G; Plessier Aurelie; Raffa Sebastian; Darwish Murad Sarwa; Heller Jörg; Hadengue Antoine; Chagneau Carine; Elias Elwyn; Primignani Massimo; Garcia-Pagan Juan-Carlos; Valla Dominique C; Janssen Harry L A;
Paroxysmal nocturnal hemoglobinuria in Budd-Chiari Syndrome: findings from a cohort study.
Journal of hepatology 2009;51(4):696-706.
-
2009: Buster Erik H C J; Flink Hajo J; Simsek Halis; Heathcote E Jenny; Sharmila Sachithanandan; Kitis George E; Gerken Guido; Buti Maria; de Vries Richard A; Verhey Elke; Hansen Bettina E; Janssen Harry L A
Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients.
The American journal of gastroenterology 2009;104(10):2449-57.
-
2009: Darwish Murad Sarwa; Plessier Aurelie; Hernandez-Guerra Manuel; Fabris Federica; Eapen Chundamannil E; Bahr Matthias J; Trebicka Jonel; Morard Isabelle; Lasser Luc; Heller Joerg; Hadengue Antoine; Langlet Philippe; Miranda Helena; Primignani Massimo; Elias Elwyn; Leebeek Frank W; Rosendaal Frits R; Garcia-Pagan Juan-Carlos; Valla Dominique C; Janssen Harry L A;
Etiology, management, and outcome of the Budd-Chiari syndrome.
Annals of internal medicine 2009;151(3):167-75.
-
2009: Janssen Harry L A; Reijnders Jurriën G P
Treatment with nucleos(t)ide analogues in chronic hepatitis B: where does the road map lead us?
Journal of hepatology 2009;51(1):1-3.
-
2009: Janssen Harry L A; Buster Erik H C J
Comments on the EASL practice guidelines for the management of chronic hepatitis B: controversies in interferon-based therapy.
Journal of hepatology 2009;51(1):224-6.
-
2009: Pan Qiuwei; Henry Scot D; Metselaar Herold J; Scholte Bob; Kwekkeboom Jaap; Tilanus Hugo W; Janssen Harry L A; van der Laan Luc J W
Combined antiviral activity of interferon-alpha and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing.
Journal of molecular medicine (Berlin, Germany) 2009;87(7):713-22.
-
2009: Pan Qiuwei; Tilanus Hugo W; Janssen Harry L A; van der Laan Luc J W
Prospects of RNAi and microRNA-based therapies for hepatitis C.
Expert opinion on biological therapy 2009;9(6):713-24.
-
2009: Reijnders Jurriën G P; Pas Suzan D; Schutten Martin; de Man Robert A; Janssen Harry L A
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.
Journal of hepatology 2009;50(4):674-83.
-
2009: Hoekstra J; Janssen H L A
Vascular liver disorders (II): portal vein thrombosis.
The Netherlands journal of medicine 2009;67(2):46-53.
-
2009: Reijnders J G P; Leemans W F; Hansen B E; Pas S D; de Man R A; Schutten M; Janssen H L A
On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks.
Journal of viral hepatitis 2009;16(2):113-20.
-
2009: Liu Bisheng; Woltman Andrea M; Janssen Harry L A; Boonstra Andre
Modulation of dendritic cell function by persistent viruses.
Journal of leukocyte biology 2009;85(2):205-14.
-
2009: Op den Brouw Marjoleine L; Binda Rekha S; van Roosmalen Mark H; Protzer Ulrike; Janssen Harry L A; van der Molen Renate G; Woltman Andrea M
Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus.
Immunology 2009;126(2):280-9.
-
2009: Woltman Andrea M; Ter Borg Martijn J; Binda Rekha S; Sprengers Dave; von Blomberg B Mary E; Scheper Rik J; Hayashi Kunihiko; Nishi Nobusuke; Boonstra André; van der Molen Renate; Janssen Harry L A
Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial.
Antiviral therapy 2009;14(6):809-18.
-
2009: Hofman Albert; Breteler Monique M B; van Duijn Cornelia M; Janssen Harry L A; Krestin Gabriel P; Kuipers Ernst J; Stricker Bruno H Ch; Tiemeier Henning; Uitterlinden André G; Vingerling Johannes R; Witteman Jacqueline C M
The Rotterdam Study: 2010 objectives and design update.
European journal of epidemiology 2009;24(9):553-72.
-
2008: Smalberg Jasper H; Spaander Manon V M C W; Jie Kon-Siong G; Pattynama Peter M T; van Buuren Henk R; van den Berg Bart; Janssen Harry L A; Leebeek Frank W G
Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.
Thrombosis and haemostasis 2008;100(6):1084-8.
-
2008: Reijnders Jurriën G P; Janssen Harry L A
How effective is adefovir dipivoxil plus lamivudine for the treatment of lamivudine-resistant chronic hepatitis B?
Nature clinical practice. Gastroenterology & hepatology 2008;5(12):668-9.
-
2008: Stoop Jeroen N; Claassen Mark A A; Woltman Andrea M; Binda Rekha S; Kuipers Ernst J; Janssen Harry L A; van der Molen Renate G; Boonstra Andre
Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.
Clinical immunology (Orlando, Fla.) 2008;129(3):419-27.
-
2008: Schiff Eugene; Simsek Halis; Lee William M; Chao You-Chen; Sette Hoel; Janssen Harry L A; Han Steven-Huy; Goodman Zachary; Yang Joanna; Brett-Smith Helena; Tamez Ricardo
Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.
The American journal of gastroenterology 2008;103(11):2776-83.
-
2008: Darwish Murad Sarwa; Dom Veerle A L; Ritman Erik L; de Groen Piet C; Beigley Patricia E; Abraham Susan C; Zondervan Pieter E; Janssen Harry L A
Early changes of the portal tract on microcomputed tomography images in a newly-developed rat model for Budd-Chiari syndrome.
Journal of gastroenterology and hepatology 2008;23(10):1561-6.
-
2008: Hoekstra J; Janssen H L A
Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome.
The Netherlands journal of medicine 2008;66(8):334-9.
-
2008: Garcia-Pagán Juan Carlos; Heydtmann Mathis; Raffa Sebastian; Plessier Aurélie; Murad Sarwa; Fabris Federica; Vizzini Giovanni; Abraldes Juan Gonzales; Olliff Simon; Nicolini Antonio; Luca Angelo; Primignani Massimo; Janssen Harry L A; Valla Dominique; Elias Elwyn; Bosch Jaume;
TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.
Gastroenterology 2008;135(3):808-15.
-
2008: Op den Brouw M L; de Jong M A W P; Ludwig I S; van der Molen R G; Janssen H L A; Geijtenbeek T B H; Woltman A M
Branched oligosaccharide structures on HBV prevent interaction with both DC-SIGN and L-SIGN.
Journal of viral hepatitis 2008;15(9):675-83.
-
2008: Leemans Wilhelmus F; Niesters Hubert G; van der Eijk Annemiek A; Janssen Harry L; Schalm Solko W; de Man Robert A
Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
European journal of gastroenterology & hepatology 2008;20(8):773-7.
-
2008: Buster Erik H C J; Flink Hajo J; Cakaloglu Yilmaz; Simon Krzysztof; Trojan Jörg; Tabak Fehmi; So Thomas M K; Feinman S Victor; Mach Tomasz; Akarca Ulus S; Schutten Martin; Tielemans Wanda; van Vuuren Anneke J; Hansen Bettina E; Janssen Harry L A
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.
Gastroenterology 2008;135(2):459-67.
-
2008: de Bruijne J; Buster E H C J; Gelderblom H C; Brouwer J T; de Knegt R J; van Erpecum K J; Schalm S W; Bakker C M; Zaaijer H L; Janssen H L A; Reesink H W;
Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
The Netherlands journal of medicine 2008;66(7):311-22.
-
2008: Buster E H C J; van Erpecum K J; Schalm S W; Zaaijer H L; Brouwer J T; Gelderblom H C; de Knegt R J; Minke Bakker C; Reesink H W; Janssen H L A;
Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
The Netherlands journal of medicine 2008;66(7):292-306.
-
2008: Sprengers Dave; Sillé Fenna C M; Derkow Katja; Besra Gurdyal S; Janssen Harry L A; Schott Eckart; Boes Marianne
Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.
Gastroenterology 2008;134(7):2132-43.
-
2008: Veldt Bart J; Chen Wendong; Heathcote E Jenny; Wedemeyer Heiner; Reichen Juerg; Hofmann W Peter; de Knegt Robert J; Zeuzem Stefan; Manns Michael P; Hansen Bettina E; Schalm Solko W; Janssen Harry L A
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
Hepatology (Baltimore, Md.) 2008;47(6):1856-62.
-
2008: ter Borg M J; Hansen B E; Bigot G; Haagmans B L; Janssen H L A
ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2008;42(2):160-4.
-
2008: Kiladjian Jean-Jacques; Cervantes Francisco; Leebeek Franck W G; Marzac Christophe; Cassinat Bruno; Chevret Sylvie; Cazals-Hatem Dominique; Plessier Aurélie; Garcia-Pagan Juan-Carlos; Darwish Murad Sarwa; Raffa Sebastian; Janssen Harry L A; Gardin Claude; Cereja Sophie; Tonetti Carole; Giraudier Stéphane; Condat Bertrand; Casadevall Nicole; Fenaux Pierre; Valla Dominique C
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.
Blood 2008;111(10):4922-9.
-
2008: Spaander Manon C W; Darwish Murad Sarwa; van Buuren Henk R; Hansen Bettina E; Kuipers Ernst J; Janssen Harry L A
Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study.
Gastrointestinal endoscopy 2008;67(6):821-7.
-
2008: Gutteling Jolie J; Darlington Anne-Sophie E; Janssen Harry L A; Duivenvoorden Hugo J; Busschbach Jan J V; de Man Robert A
Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(2):195-205.
-
2008: Darwish Murad Sarwa; Luong Trinh K; Pattynama Peter M T; Hansen Bettina E; van Buuren Henk R; Janssen Harry L A
Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(2):249-56.
-
2008: Leemans W F; Janssen H L A; Niesters H G M; de Man R A
Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.
Journal of viral hepatitis 2008;15(2):108-14.
-
2008: ter Borg M J; Leemans W F; de Man R A; Janssen H L A
Exacerbation of chronic hepatitis B infection after delivery.
Journal of viral hepatitis 2008;15(1):37-41.
-
2008: Buster Erik H C J; Schalm Solko W; Janssen Harry L A
Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
Best practice & research. Clinical gastroenterology 2008;22(6):1093-108.
-
2008: Boonstra Andre; Woltman Andrea M; Janssen Harry L A
Immunology of hepatitis B and hepatitis C virus infections.
Best practice & research. Clinical gastroenterology 2008;22(6):1049-61.
-
2007: Spaander V M C W; van Buuren H R; Janssen H L A
Review article: The management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults.
Alimentary pharmacology & therapeutics 2007;26 Suppl 2():203-9.
-
2007: Veldt Bart J; Heathcote E Jenny; Wedemeyer Heiner; Reichen Juerg; Hofmann W Peter; Zeuzem Stefan; Manns Michael P; Hansen Bettina E; Schalm Solko W; Janssen Harry L A
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.
Annals of internal medicine 2007;147(10):677-84.
-
2007: Bergmann Jilling F; Vrolijk Jan M; van der Schaar Peter; Vroom Brigitte; van Hoek Bart; van der Sluys Veer Annet; de Vries Richard A; Verhey Elke; Hansen Bettina E; Brouwer Johannes T; Janssen Harry L A; Schalm Solko W; de Knegt Robert J
Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(9):1217-25.
-
2007: Sprengers D; van der Molen R G; Binda R; Kusters J G; de Man R A; Niesters H G M; Schalm S W; Janssen H L A
In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection.
Journal of viral hepatitis 2007;14(10):743-9.
-
2007: Flink H J; Buster E H C J; Merican I; Nevens F; Kitis G; Cianciara J; de Vries R A; Hansen B E; Schalm S W; Janssen H L A
Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.
Gut 2007;56(10):1485-6.
-
2007: Pan Qiu-Wei; Henry Scot D; Scholte Bob J; Tilanus Hugo W; Janssen Harry L A; van der Laan Luc J W
New therapeutic opportunities for hepatitis C based on small RNA.
World journal of gastroenterology : WJG 2007;13(33):4431-6.
-
2007: Stoop Jeroen N; Woltman Andrea M; Biesta Paula J; Kusters Johannes G; Kuipers Ernst J; Janssen Harry L A; van der Molen Renate G
Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.
Hepatology (Baltimore, Md.) 2007;46(3):699-705.
-
2007: Veldt Bart J; van der Vliet Hans J J; von Blomberg B Mary E; van Vlierberghe Hans; Gerken Guido; Nishi Nobusuke; Hayashi Kunihiko; Scheper Rik J; de Knegt Robert J; van den Eertwegh Alfons J M; Janssen Harry L A; van Nieuwkerk Carin M J
Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.
Journal of hepatology 2007;47(3):356-65.
-
2007: Buster Erik H C J; Hansen Bettina E; Buti Maria; Delwaide Jean; Niederau Claus; Michielsen Peter P; Flisiak Robert; Zondervan Pieter E; Schalm Solko W; Janssen Harry L A;
Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.
Hepatology (Baltimore, Md.) 2007;46(2):388-94.
-
2007: Hou Jinlin; Schilling Ralf; Janssen Harry L A; Hansen Bettina E; Heijtink Rudolf; Sablon Erwin; Williams Roger; Lau George K K; Schalm Solko W; Naoumov Nikolai V
Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.
Journal of medical virology 2007;79(8):1055-63.
-
2007: Darwish Murad Sarwa; Kim W Ray; de Groen Piet C; Kamath Patrick S; Malinchoc Michael; Valla Dominique-Charles; Janssen Harry L A
Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(6):867-74.
-
2007: van der Laan Luc J W; Taimr Pavel; Kok Alice; Sprengers Dave; Zondervan Pieter E; Tilanus Hugo W; Janssen Harry L A
Flowcytometric quantitation of hepatitis B viral antigens in hepatocytes from regular and fine-needle biopsies.
Journal of virological methods 2007;142(1-2):189-97.
-
2007: Leemans W F; Janssen H L A; de Man R A
Future prospectives for the management of chronic hepatitis B.
World journal of gastroenterology : WJG 2007;13(18):2554-67.
-
2007: Buster E H C J; van der Eijk A A; de Man R A; Janssen H L A; Schalm S W
Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety.
Journal of viral hepatitis 2007;14(5):350-4.
-
2007: Veldt Bart J; Schalm Solko W; Janssen Harry L A
Severe allergic eczema due to pegylated alpha-interferon may abate after switching to daily conventional alpha-interferon.
Journal of clinical gastroenterology 2007;41(4):432.
-
2007: Stoop Jeroen N; van der Molen Renate G; Kuipers Ernst J; Kusters Johannes G; Janssen Harry L A
Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B.
Virology 2007;361(1):141-8.
-
2007: de Bruijne Emile L E; Darwish Murad Sarwa; de Maat Moniek P M; Tanck Michael W T; Haagsma Elizabeth B; van Hoek Bart; Rosendaal Frits R; Janssen Harry L A; Leebeek Frank W G;
Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
Thrombosis and haemostasis 2007;97(2):181-5.
-
2006: Smalberg Jasper H; Darwish Murad Sarwa; Braakman Eric; Valk Peter J; Janssen Harry L A; Leebeek Frank W G
Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome.
Haematologica 2006;91(12):1712-3.
-
2006: Janssen Harry L A; Leebeek Frank W G
JAK2 mutation: The best diagnostic tool for myeloproliferative disease in splanchnic vein thrombosis?
Hepatology (Baltimore, Md.) 2006;44(6):1391-3.
-
2006: Flink Hajo J; Hansen Bettina E; Heathcote E Jenny; Feinman S Victor; Simsek Halis; Karayalcin Selim; Mach Tomasz; Leemans Wim F; de Man Robert A; Verhey Elke; Schalm Solko W; Janssen Harry L A;
Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine.
The American journal of gastroenterology 2006;101(11):2523-9.
-
2006: van der Molen Renate G; Sprengers Dave; Biesta Paula J; Kusters Johannes G; Janssen Harry L A
Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV.
Hepatology (Baltimore, Md.) 2006;44(4):907-14.
-
2006: ter Borg Martijn J; van Zonneveld Monika; Zeuzem Stefan; Senturk Hakan; Akarca Ulus S; Simon Christopher; Hansen Bettina E; Haagmans Bart L; de Man Robert A; Schalm Solko W; Janssen Harry L A;
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response.
Hepatology (Baltimore, Md.) 2006;44(3):721-7.
-
2006: Lisman T; Adelmeijer J; de Groot P G; Janssen H L A; Leebeek F W G
No evidence for an intrinsic platelet defect in patients with liver cirrhosis--studies under flow conditions.
Journal of thrombosis and haemostasis : JTH 2006;4(9):2070-2.
-
2006: Darwish Murad Sarwa; Janssen Harry L A
Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2.
The New England journal of medicine 2006;355(7):737-8; author reply 738.
-
2006: Sprengers Dave; van der Molen Renate G; Kusters Johannes G; De Man Robert A; Niesters Hubert G M; Schalm Solko W; Janssen Harry L A
Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans.
Journal of hepatology 2006;45(2):182-9.
-
2006: Lisman Ton; Bongers Tamara N; Adelmeijer Jelle; Janssen Harry L A; de Maat Moniek P M; de Groot Philip G; Leebeek Frank W G
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.
Hepatology (Baltimore, Md.) 2006;44(1):53-61.
-
2006: Buster Erik H C J; Ter Borg Martijn J; Vingerling Johannes R; Janssen Harry L A
Low incidence of retinopathy during peginterferon alpha-2b and lamivudine therapy for chronic hepatitis B.
Journal of hepatology 2006;45(1):160-1; author reply 161-2.
-
2006: Buster E H C J; Janssen H L A
Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
The Netherlands journal of medicine 2006;64(6):175-85.
-
2006: van Zonneveld Monika; Zondervan Pieter E; Cakaloglu Yilmaz; Simon Christopher; Akarca Ulus S; So Thomas M K; Flink Hajo J; de Man Robert A; Schalm Solko W; Janssen Harry L A;
Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(4):399-405.
-
2006: Sprengers D; van der Molen R G; Kusters J G; Hansen B; Niesters H G M; Schalm S W; Janssen H L A
Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B.
Journal of medical virology 2006;78(5):561-8.
-
2006: Tang Thjon J; Vukosavljevic Dragica; Janssen Harry L A; Binda Rekha S; Mancham Shanta; Tilanus Hugo W; Ijzermans Jan N M; Drexhage Hemmo; Kwekkeboom Jaap
Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma.
Human pathology 2006;37(3):332-8.
-
2006: Leemans Wilhelmus F; Flink Hajo J; Janssen Harry L A; Niesters Hubert G M; Schalm Solko W; de Man Robert A
The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.
Journal of hepatology 2006;44(3):507-11.
-
2006: Flink Hajo J; van Zonneveld Monika; Hansen Bettina E; de Man Robert A; Schalm Solko W; Janssen Harry L A;
Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype.
The American journal of gastroenterology 2006;101(2):297-303.
-
2006: van der Eijk A A; Niesters H G M; Hansen B E; Heijtink R A; Janssen H L A; Schalm S W; de Man R A
Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
Journal of viral hepatitis 2006;13(2):96-103.
-
2006: Darwish Murad Sarwa; Valla Dominique-Charles; de Groen Piet C; Zeitoun Guy; Haagsma Elizabeth B; Kuipers Ernst J; Janssen Harry L A
Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.
The American journal of gastroenterology 2006;101(1):83-90.
-
2005: Janssen Harry L A; Lau George K K
Chronic hepatitis B: HBeAg seroconversion after pegylated interferon and nucleos(t)ide analogs.
Hepatology (Baltimore, Md.) 2005;42(6):1459; author reply 1459-60.
-
2005: van der Eijk Annemiek A; Niesters Hubert G M; Hansen Bettina E; Pas Suzan D; Richardus Jan H; Mostert Marijke; Janssen Harry L A; Schalm Solko W; de Man Robert A
Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients.
European journal of gastroenterology & hepatology 2005;17(11):1173-9.
-
2005: Flink H J; Sprengers D; Hansen B E; van Zonneveld M; de Man R A; Schalm S W; Janssen H L A;
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.
Gut 2005;54(11):1604-9.
-
2005: ter Borg Martijn J; Janssen Harry L A
Pegylated interferon-alpha2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B.
Annals of internal medicine 2005;143(5):391; author reply 391-2.
-
2005: Sprengers D; van der Molen R G; Kusters J G; Kwekkeboom J; van der Laan L J W; Niesters H G M; Kuipers E J; De Man R A; Schalm S W; Janssen H L A
Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis.
Journal of viral hepatitis 2005;12(5):507-12.
-
2005: Sprengers D; Janssen H L A
Immunomodulatory therapy for chronic hepatitis B virus infection in children.
Fundamental & clinical pharmacology 2005;19(4):447.
-
2005: van der Eijk A A; Hansen B E; Niesters H G M; Janssen H L A; van de Ende M; Schalm S W; de Man R A
Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.
Journal of viral hepatitis 2005;12(4):364-72.
-
2005: Tang Thjon J; Kwekkeboom Jaap; Mancham Shanta; Binda Rekha S; de Man Robert A; Schalm Solko W; Kusters Johannes G; Janssen Harry L A
Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection.
Journal of hepatology 2005;43(1):45-52.
-
2005: van Zonneveld M; Flink H J; Verhey E; Senturk H; Zeuzem S; Akarca U S; Cakaloglu Y; Simon C; So T M K; Gerken G; de Man R A; Hansen B E; Schalm S W; Janssen H L A;
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
Alimentary pharmacology & therapeutics 2005;21(9):1163-71.
-
2005: de Groot C J M; van Goor G M; Stolk M F; Kazemier G; Zondervan P E; Metselaar H J; Wanless I R; Janssen H L A
Liver failure after delivery.
Gut 2005;54(5):672, 709.
-
2005: Stoop Jeroen N; van der Molen Renate G; Baan Carla C; van der Laan Luc J W; Kuipers Ernst J; Kusters Johannes G; Janssen Harry L A
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.
Hepatology (Baltimore, Md.) 2005;41(4):771-8.
-
2005: Sprengers D; Janssen H L A
Immunomodulatory therapy for chronic hepatitis B virus infection.
Fundamental & clinical pharmacology 2005;19(1):17-26.
-
2005: van der Vliet Hans J J; Molling Johan W; von Blomberg B Mary E; Kölgen Wendy; Stam Anita G; de Gruijl Tanja D; Mulder Chris J; Janssen Harry L A; Nishi Nobusuke; van den Eertwegh Alfons J M; Scheper Rik J; van Nieuwkerk Carin J M
Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.
Clinical immunology (Orlando, Fla.) 2005;114(2):183-9.
-
2005: Janssen Harry L A; van Zonneveld Monika; Senturk Hakan; Zeuzem Stefan; Akarca Ulus S; Cakaloglu Yilmaz; Simon Christopher; So Thomas M K; Gerken Guido; de Man Robert A; Niesters Hubert G M; Zondervan Pieter; Hansen Bettina; Schalm Solko W;
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.
Lancet 2005;365(9454):123-9.
-
2004: van der Molen Renate G; Sprengers Dave; Binda Rekha S; de Jong Esther C; Niesters Hubert G M; Kusters Johannes G; Kwekkeboom Jaap; Janssen Harry L A
Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.
Hepatology (Baltimore, Md.) 2004;40(3):738-46.
-
2004: Sprengers Dave; van der Molen Renate G; Kusters Johannes G; Janssen Harry L A
Coarse vs. fine needle aspiration biopsy.
Journal of hepatology 2004;41(3):503-4; author reply 504.
-
2004: Janssen Harry L A; van Zonneveld Monika; van Nunen Andeltje B; Niesters Hubert G M; Schalm Solko W; de Man Robert A
Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.
European journal of gastroenterology & hepatology 2004;16(8):801-7.
-
2004: Vrolijk J M; Tang T J; Kwekkeboom J; Haagmans B L; Herscheid A J; Kusters J G; Janssen H L A; Brouwer J T; Schalm S W
Monitoring intrahepatic CD8+ T cells by fine-needle aspiration cytology in chronic hepatitis C infection.
Journal of viral hepatitis 2004;11(4):342-8.
-
2004: Janssen Harry L A; van Zonneveld Monika; Schalm Solko W
Hepatitis B.
The New England journal of medicine 2004;350(26):2719-20.
-
2004: Janssen Harry L A; Garcia-Pagan Juan-Carlos; Valla Dominique-Charles
The Budd-Chiari syndrome.
The New England journal of medicine 2004;350(18):1906-8; author reply 1906-8.
-
2004: van Zonneveld Monika; Honkoop Pieter; Hansen Bettina E; Niesters Hubertus G M; Darwish Murad Sarwa; de Man Robert A; Schalm Solko W; Janssen Harry L A
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
Hepatology (Baltimore, Md.) 2004;39(3):804-10.
-
2004: Darwish Murad Sarwa; Valla Dominique-Charles; de Groen Piet C; Zeitoun Guy; Hopmans Judith A M; Haagsma Elizabeth B; van Hoek Bart; Hansen Bettina E; Rosendaal Frits R; Janssen Harry L A
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome.
Hepatology (Baltimore, Md.) 2004;39(2):500-8.
-
2004: van der Eijk Annemiek A; Niesters Hubert G M; Götz Hannelore M; Janssen Harry L A; Schalm Solko W; Osterhaus Albert D M E; de Man Robert A
Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;29(2):92-4.
-
2004: Tang Thjon J; de Man Robert A; Kusters Johannes G; Kwekkeboom Jaap; Hop Wim C J; van der Molen Renate G; Schalm Solko W; Janssen Harry L A
Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.
Journal of medical virology 2004;72(2):215-22.
-
2004: Tanis W; Mancham S; Binda R; Janssen H L A; Bezemer G; IJzermans J N M; Tilanus H W; Laman J D; de Wit H; Drexhage H A; Schalm S W; Kwekkeboom J
Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cells.
Clinical immunology (Orlando, Fla.) 2004;110(1):81-8.
-
2003: Vrolijk Jan M; Kwekkeboom Jaap; Janssen Harry L A; Hansen Bettina E; Zondervan Pieter E; Osterhaus Albert D M E; Schalm Solko W; Haagmans Bart L
Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection.
The Journal of infectious diseases 2003;188(10):1528-32.
-
2003: Tang Thjon J; Janssen Harry L A; Kusters Johannes G; de Man Robert A; Schalm Solko W; Kwekkeboom Jaap
The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy technique.
FEMS immunology and medical microbiology 2003;39(1):69-72.
-
2003: Janssen Harry L A; Higuchi Hajime; Abdulkarim Ahmad; Gores Gregory J
Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression.
Journal of hepatology 2003;39(3):414-20.
-
2003: van Zonneveld M; van Nunen A B; Niesters H G M; de Man R A; Schalm S W; Janssen H L A
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.
Journal of viral hepatitis 2003;10(4):294-7.
-
2003: Tang T J; Kwekkeboom J; Laman J D; Niesters H G M; Zondervan P E; de Man R A; Schalm S W; Janssen H L A
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection.
Journal of viral hepatitis 2003;10(3):159-67.
-
2003: Janssen Harry L A; Garcia-Pagan Juan-Carlos; Elias Elwyn; Mentha Gilles; Hadengue Antoine; Valla Dominique-Charles;
Budd-Chiari syndrome: a review by an expert panel.
Journal of hepatology 2003;38(3):364-71.
-
2003: van Nunen A B; Hansen B E; Suh D J; Löhr H F; Chemello L; Fontaine H; Heathcote J; Song B C; Janssen H L A; de Man R A; Schalm S W
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.
Gut 2003;52(3):420-4.
-
2003: Sprengers D; Janssen H L A; Kwekkeboom J; Niesters H G M; de Man R A; Schalm S W
In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis B.
Journal of viral hepatitis 2003;10(1):7-9.
-
2002: Schalm S W; De Man R A; Janssen H L A
Combination and newer therapies for chronic hepatitis B.
Journal of gastroenterology and hepatology 2002;17 Suppl 3():S338-41.
-
2002: Sprengers D; van Gelder T; Zondervan P E; Niesters H G M; Janssen H L A; de Man R A
[Fatal fibrosing cholestatic hepatitis following renal transplantation]
Nederlands tijdschrift voor geneeskunde 2002;146(29):1380-4.
-
2002: van der Eijk A A; Doorduijn J K; Janssen H L A; Schalm S W; Niesters H G M; de Man R A
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma]
Nederlands tijdschrift voor geneeskunde 2002;146(24):1140-4.
-
2002: Janssen Harry L A; Tan Adriaan C I T L; Tilanus Hugo W; Metselaar Herold J; Zondervan Pieter E; Schalm Solko W
Pseudo-Budd-Chiari Syndrome: decompensated alcoholic liver disease mimicking hepatic venous outflow obstruction.
Hepato-gastroenterology 2002;49(45):810-2.
-
2001: van Nunen A B; Janssen H L; Wolters L M; Niesters H G; de Man R A; Schalm S W
Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?
Antiviral research 2001;52(2):139-46.
-
2001: Janssen H L; Wijnhoud A; Haagsma E B; van Uum S H; van Nieuwkerk C M; Adang R P; Chamuleau R A; van Hattum J; Vleggaar F P; Hansen B E; Rosendaal F R; van Hoek B
Extrahepatic portal vein thrombosis: aetiology and determinants of survival.
Gut 2001;49(5):720-4.
-
2001: Tang T J; Batts K P; de Groen P C; van Hoek B; Haagsma E B; Hop W C; Janssen H L
The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome.
Journal of hepatology 2001;35(3):338-43.
-
2001: Lisman T; Leebeek F W; Mosnier L O; Bouma B N; Meijers J C; Janssen H L; Nieuwenhuis H K; De Groot P G
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis.
Gastroenterology 2001;121(1):131-9.
-
2001: Heijtink R A; Janssen H L; Hop W C; Osterhaus A D; Schalm S W
Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replication.
Journal of medical virology 2001;63(3):217-9.
-
2000: Janssen H L; Meinardi J R; Vleggaar F P; van Uum S H; Haagsma E B; van Der Meer F J; van Hattum J; Chamuleau R A; Adang R P; Vandenbroucke J P; van Hoek B; Rosendaal F R
Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.
Blood 2000;96(7):2364-8.
-
2000: Heijtink R A; Janssen H L; Hop W C; Osterhaus A D; Schalm S W
Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy.
Journal of viral hepatitis 2000;7(5):382-6.
-
2000: van der Vlies C H; Tang T J; Niesters H G; Zondervan P E; Janssen H L; de Man R A
Acute hepatitis C infection: an indication for alfa interferon therapy?
The Netherlands journal of medicine 2000;57(1):30-3.
-
2000: Tang T J; Janssen H L; van der Vlies C H; de Man R A; Metselaar H J; Tilanus H W; de Marie S
Aspergillus osteomyelitis after liver transplantation: conservative or surgical treatment?
European journal of gastroenterology & hepatology 2000;12(1):123-6.
-
1999: Janssen H L; Gerken G; Carreño V; Marcellin P; Naoumov N V; Craxi A; Ring-Larsen H; Kitis G; van Hattum J; de Vries R A; Michielsen P P; ten Kate F J; Hop W C; Heijtink R A; Honkoop P; Schalm S W
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).
Hepatology (Baltimore, Md.) 1999;30(1):238-43.
Sign-in to see more
